amikacin has been researched along with Escherichia coli Infections in 116 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 27 (23.28) | 18.7374 |
1990's | 14 (12.07) | 18.2507 |
2000's | 26 (22.41) | 29.6817 |
2010's | 41 (35.34) | 24.3611 |
2020's | 8 (6.90) | 2.80 |
Authors | Studies |
---|---|
Barth, AL; Castanheira, M; Gales, AC; Nicoletti, AG; Pereira, AS; Pignatari, AC | 1 |
Caniça, M; Ferreira, E; Leitão, J; Manageiro, V; Mendonça, N | 1 |
Afkou, Z; Ikonomidis, A; Labrou, M; Maniatis, AN; Pournaras, S; Sofianou, D; Tsakris, A | 1 |
Adams-Haduch, JM; Doi, Y; Paterson, DL | 1 |
Arakawa, Y; Suzuki, S; Wachino, J; Yamane, K | 1 |
Apisarnthanarak, A; Kiratisin, P; Laesripa, C; Saifon, P | 1 |
Cauda, R; D'Inzeo, T; De Pascale, G; Fadda, G; Fiori, B; Leone, F; Rossi, M; Sali, M; Sanguinetti, M; Spanu, T; Trecarichi, EM; Tumbarello, M | 1 |
Cattoir, V; Nordmann, P; Poirel, L | 1 |
Alfa, M; Kibsey, P; Loo, V; McGeer, A; Nigrin, J; Peirano, G; Pienaar, C; Pitout, JD; Richardson, D; Toye, B | 1 |
Blango, MG; Mulvey, MA | 1 |
Carmeli, Y; Chmelnitsky, I; Goren, MG; Navon-Venezia, S | 1 |
Badal, RE; Baquero, F; Bouchillon, SK; Cantón, R; Hawser, SP; Hoban, DJ | 1 |
Haider Naqvi, SZ; Malik, A; Muddassir, M; Mumtaz, K; Munir, S; Raza, A; Shoaib Ahmed, S; Waqas, K | 1 |
Chen, J; Liu, W; Zhao, F | 1 |
Caljon, B; Crombé, F; De Geyter, D; Demuyser, T; Janssen, T; Muyldermans, A; Piérard, D; Seyler, L; Vanstokstraeten, R; Wybo, I | 1 |
Ahmed, F; Akter, A; Alam, S; Jafar, T; Saha, O; Saha, SR; Sultana, KF | 1 |
Baidya, R; Belbase, A; Dhakal, L; Govinda Prajapati, K; Kishor Bimali, N; Raya, S | 1 |
Dobashi, M; Ikeda, M; Ishii, J; Koguchi, D; Murakami, Y | 1 |
Altun, B; Cakar, A; Demirci-Duarte, S; Eser, OK; Gur, D; Sancak, B; Unalan-Altintop, T | 1 |
Cui, ZH; Fang, LX; Li, XJ; Liao, XP; Liu, YH; Ni, WN; Sun, J; Tang, T; Yu, Y; Zheng, ZJ; Zhong, ZX; Zhou, YF | 1 |
Ahn, ST; Han, DE; Kim, JW; Lee, DH; Moon, DG; Oh, MM; Park, HS | 1 |
Feng, Y; Liao, XP; Liu, YH; Sun, J; Tao, MT; Yang, RS; Zhou, YF | 1 |
Béchet, S; Biscardi, S; Cohen, R; Madhi, F; Poey, N | 1 |
Ashraf, T; Darwish, D; Ghazawi, A; Mohsin, J; Pál, T; Petersen, JE; Sonnevend, A | 1 |
Ali, I; Shabbir, M | 1 |
Amin, S; Dhrolia, MF; Mannan, A | 1 |
Batzias, GC; Delis, GA; Koutsoviti-Papadopoulou, M; Siarkou, VI; Vingopoulou, EI | 1 |
Abdelwahab, SI; Dafalla, OME; Homeida, HE; Taha, MME | 1 |
Gao, Y; Guo, R; Lu, L; Shen, H; Yu, Y; Zhu, C | 1 |
Aneja, T; Barathi, D; Chaturvedula, L; Keepanasseril, A; Nair, PP | 1 |
Beliavsky, A; Bernick, J; Bogoch, II | 1 |
Attwood, M; Bowker, KE; Kim, A; Krause, KM; MacGowan, AP; Noel, AR | 1 |
Guo, H; Jiang, Z; Ju, Z; Qiu, J; Sun, S; Yang, J; Zhao, X | 1 |
Chae, JY; Kim, JW; Moon, du G; Oh, MM; Park, MG; Yoon, CY | 1 |
Batura, D; Gopal Rao, G | 1 |
Belghiti, J; Bert, F; Dondero, F; Durand, F; Larroque, B; Moreau, R; Nicolas-Chanoine, MH; Paugam-Burtz, C | 1 |
Aganj, M; Ali, L; Sakinc, T; Shokoohizadeh, L; Soleimani, N | 1 |
Chen, PY; Chien, YL; Chou, CM; Fu, LS; Huang, CM; Huang, FL; Lin, CF; Wu, TH | 1 |
Dimic, ND; Milovanovic, DR; Mitrovic, SLj; Radovanovic, DM; Radovanovic, M; Vojinovic, RH | 1 |
Batbaatar, G; Bolormaa, E; Huang, AH; Huang, YT; Kao, CY; Khosbayar, T; Udval, U; Urangoo, Z; Wu, HM; Wu, JJ; Yan, JJ | 1 |
Deng, H; Fang, LX; Li, L; Li, XP; Liao, XP; Liu, YH; Sun, J; Xia, J; Yang, RS | 1 |
Guan, Z; Jiang, W; Lei, C; Li, Q; Liu, B; Pan, Y; Wang, H; Xu, C; Yang, C; Yang, Y; Zhang, A; Zhang, D | 1 |
Agudelo, M; Rodriguez, CA; Vesga, O; Zuluaga, AF | 1 |
Aksaray, S; Avcıküçük, H; Başustaoğlu, A; Kaşkatepe, B; Süzük, S | 1 |
Hung, YP; Ko, WC; Lee, JC; Li, CW; Li, MC; Lin, HJ; Liu, HC; Wu, YH | 1 |
Cho, SY; Choi, JH; Choi, SM; Lee, DG; Park, SH; Yoo, JH | 1 |
Dey, AC; Dey, SK; Hossain, MI; Mannan, MA; Shahidullah, M | 1 |
Ak, S; Ay Altıntop, Y; Balcı, PÖ; Budak, EE; Çalışkan, A; Çizmeci, Z; Çopur Çiçek, A; Fırat, M; Özgümüş, OB; Sancaktar, M; Sandallı, C; Sarı, F; Şay Coşkun, SU; Yağmur, G; Yıldız, N | 1 |
Nicolau, DP; Sutherland, CA; Verastegui, JE | 1 |
Alonso-Isa, M; Benítez-Sala, R; García-Rojo, E; Gil-Moradillo, J; González-Padilla, DA; Justo-Quintas, J; Lara-Isla, A; Medina-Polo, J; Passas-Martínez, JB; Sopeña-Sutil, R; Tejido-Sánchez, Á | 1 |
Cunha, CL; Fadel, MV; Leão, MT; Repka, JC | 1 |
Cisowska, A; Wojnicz, D | 1 |
Kalenić, S; Milas, J; Milas, V; Miskulin, M; Puntarić, D; Rudan, S; Vuković, D | 1 |
Asensi, MD; Carvalho-Assef, AP; Correal, JC; Goldemberg, DC; Leão, RS; Marques, EA; Silva, RV | 1 |
Armero, C; Gobernado, M; González, F; López-Quílez, A; Perpiñán, H; Sahuquillo-Arce, JM; Selva, M; Vanaclocha, H | 1 |
Ersoy, Y; Görgeç, S; Kuzucu, C; Yetkin, F | 1 |
Badal, RE; Bouchillon, SK; Cantón, R; Hackel, M; Hawser, SP; Hoban, DJ; Lascols, C | 1 |
Hu, Y; Xiao, Y | 1 |
Argyropoulou, A; Chrysouli, Z; Daikos, GL; Galani, I; Giamarellou, H; Panagea, T; Petrikkos, G; Plakias, G; Poulakou, G; Psichogiou, M; Souli, M; Stefanou, I | 1 |
Chantier, E; Gouache, E; Hubert, N; Rivière, MF | 1 |
Ferrari, F; Goldstein, I; Marquette, CH; Nicolas-Robin, A; Rouby, JJ; Wallet, F | 1 |
Dai, G; Li, WW; Yan, ZW | 1 |
Jeong, HJ | 1 |
Brinkmann, G; Hellwege, HH; Kaczmarek, D; Kammler, G; Sonntag, J | 1 |
Bertran, S; Gómez, E; Jiménez de Anta, MT; Julià, A; Ruiz, J; Sauca, G; Vila, J; Vila, X | 1 |
Antonopoulou, A; Baziaka, F; Giamarellos-Bourboulis, EJ; Giamarellou, H; Kousoulas, V; Koutoukas, P; Panagou, C; Perrea, D; Sabracos, L | 1 |
Adamis, T; Baziaka, F; Giamarellos-Bourboulis, E; Giamarellou, H; Karayannacos, P; Koutoukas, P; Plachouras, D; Raftogiannis, M; Sabracos, L; Tsaganos, T | 1 |
Bennett, PM; Cassar, C; Enne, VI; Sprigings, K; Woodward, MJ | 1 |
Aksaranugraha, S; Kittisomprayoonkul, W; Suankratay, C; Sukonthamarn, K; Tantisiriwat, N; Tantisiriwat, W; Unhasuta, C | 1 |
Alexiou, VG; Falagas, ME; Kremastinou, J; Marini-Mastrogiannaki, A; Polemis, M; Vatopoulos, AC | 1 |
Basu, K; Biswas, A; Chatterjee, A; Chatterjee, S; Ghosh, JK | 1 |
Catarinelli, L; Celi, F; Crapa, G; De Rosa, F; Frongillo, RF; Luzzi, L; Moretti, MV; Palumbo, M; Rossi, A; Sciannameo, F | 1 |
Bernard, C; Gaya, H; Klastersky, J; Ryff, JC; Zinner, SH | 1 |
Connor, E; Goessler, M; Wallen, L; Yogev, R; Zeller, WP | 1 |
Kajiyama, G; Nagel, DA; Schurman, DJ | 1 |
Bis, W; Jeljaszewicz, J; Kazanowski, A; Kuzniewski, P; Molska, J; Włodarczak, K | 1 |
Bowman, CM; Kaiser, AB; McGee, ZA; McKee, KT; Trujillo, H; Wright, PF | 1 |
Bubrick, MP; Granja, JA; Jacobs, DM; Ney, AL; Schuster, PA; Tsukayama, DT | 1 |
Song, GD | 1 |
Sturm, W | 1 |
Leal del Rosal, P | 1 |
Esparza-Ahumada, S; Morfin-Otero, R; Rodriguez-Noriega, E | 1 |
Principi, N; Viganò, A | 1 |
Galandiuk, S; Myers, S; Polk, HC; Wrightson, WR; Young, S | 1 |
McClure, JT; Rosin, E | 1 |
Bartsokas, C; Delis, D; Kafetzis, DA; Maltezou, HC; Mavrikou, M; Paraskakis, I; Siafas, C | 1 |
Chastagner, P; Eyer, D; Lozniewski, A; Plesiat, P; Plouvier, E; Sommelet, D | 1 |
Burke, TJ; Campbell, KL; Kakoma, I; Kim, CH; Koo, HY; McKiernan, BC; Oluoch, AO; Siegel, AM; Weisiger, RM | 1 |
Acevedo, A; Escudero, A; Fernández-Rañada, JM; Gil-Fernández, JJ; Martínez, E; Martínez-Chamorro, C | 1 |
Mandaleris, CD; Sande, MA; Strausbaugh, LJ | 1 |
Fortner, CL; Hahn, DM; Schimpff, SC; Standiford, HC; Wiernik, PH; Young, VM | 1 |
Greenman, RL; Hoffman, TA; Sklaver, AR | 1 |
Bettelheim, KA; Humble, MW | 1 |
Agudelo, N; de Vidal, EL; Manotas, R; Ramirez, JI; Trujillo, H; Uribe, A; Zapata, CT; Zuluaga, AI | 1 |
Aboul-Enein, M; Sherif, M; Soliman, O | 1 |
McGee, ZA; Meacham, WF; Oldfield, EH; Wirt, TC | 1 |
Hirshman, HP; Nagel, DA; Schurman, DJ | 1 |
Bodey, GP; Feld, R; Rodriguez, V; Valdivieso, M | 1 |
Hofstetter, A; Staehler, G | 1 |
Becerra-Muñoz, E; Bravo-Sandoval, J; Cinco-Espinoza, G; Flores-Mercado, F; Galindo-Hernández, E; Ramírez-López, D | 1 |
Lüthy, R | 1 |
Matsumoto, F; Saigusa, M; Saito, A; Ueda, Y | 1 |
Ciebieda, I; Denys, A; Ferszt, T; Korczak, E | 1 |
Clément, C; Demingeon, G; Holzapfel, L; Madinier, G; Ohen, F; Villette, P | 1 |
Ba, M; Cissé, MF; Ouangre, AR; Samb, A; Sow, AI | 1 |
Goto, T; Kawahara, K; Kawahara, M; Mahinose, S; Mizuma, Y; Ohi, Y; Sakamoto, N | 1 |
Hirano, S; Hisazumi, H; Motoi, I; Ohkawa, M; Okasho, A | 1 |
Kay, MA; McCabe, ED | 1 |
Aydin, M; Dervişoğlu, AA; Unal, S | 1 |
Chavarría, JF; Faingezicht, I | 1 |
Bodunkova, LE; Ivanitskaia, LP; Kudinova, MK; Samoĭlova, LN; Viadro, MM | 1 |
Auckenthaler, R; Marchou, B; Michéa-Hamzehpour, M; Pechère, JC | 1 |
Fasching, CE; Gerding, DN; Moody, JA; Peterson, LR | 1 |
Lees, GE; Rogers, KS; Simpson, RB | 1 |
Gómez, JG; Jiménez-Cruz, JF; Tormo, FB | 1 |
Borges, LF; Chapman, PH | 1 |
4 review(s) available for amikacin and Escherichia coli Infections
Article | Year |
---|---|
Acute necrotizing gastritis by Escherichia coli in a severely neutropenic patient.
Topics: Acute Disease; Amikacin; Anemia, Aplastic; Antilymphocyte Serum; Combined Modality Therapy; Cyclosporine; Drug Therapy, Combination; Escherichia coli Infections; Gastric Mucosa; Gastritis; Granulocyte Colony-Stimulating Factor; Immunosuppressive Agents; Meropenem; Methylprednisolone; Necrosis; Neutropenia; Omeprazole; Parenteral Nutrition, Total; T-Lymphocytes; Thienamycins | 2002 |
[Aminoglycoside antibiotics from clinical viewpoint].
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Drug Combinations; Enterobacteriaceae Infections; Escherichia coli Infections; Gentamicins; Glomerular Filtration Rate; Kanamycin; Klebsiella Infections; Proteus Infections; Providencia; Pseudomonas Infections; Serratia; Sisomicin; Streptomycin; Tobramycin | 1975 |
Bartholin's gland abscess in a neonate.
Topics: Abscess; Amikacin; Bartholin's Glands; Drainage; Escherichia coli Infections; Female; Humans; Infant, Newborn; Oxacillin; Vulvitis | 1989 |
Shunt infections: prevention and treatment.
Topics: Amikacin; Anti-Bacterial Agents; Bacterial Infections; Cerebrospinal Fluid Shunts; Drug Resistance, Microbial; Drug Therapy, Combination; Escherichia coli Infections; Gentamicins; Humans; Injections, Intravenous; Injections, Intraventricular; Klebsiella Infections; Leukocytes; Meningitis; Premedication; Pseudomonas Infections; Reoperation; Rifampin; Staphylococcal Infections; Staphylococcus epidermidis; Tobramycin; Vancomycin | 1985 |
10 trial(s) available for amikacin and Escherichia coli Infections
Article | Year |
---|---|
In vitro and in vivo studies of three antibiotic combinations against gram-negative bacteria and Staphylococcus aureus.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Azlocillin; Cefotaxime; Enterobacteriaceae; Escherichia coli; Escherichia coli Infections; Humans; In Vitro Techniques; Klebsiella; Klebsiella Infections; Mice; Mice, Inbred BALB C; Penicillins; Pseudomonas aeruginosa; Serratia; Staphylococcus aureus | 1981 |
Single-dose amikacin treatment of first childhood E. coli lower urinary tract infections.
Topics: Amikacin; Child; Child, Preschool; Clinical Trials as Topic; Escherichia coli Infections; Female; Humans; Infant; Injections, Intramuscular; Kanamycin; Sulfisoxazole; Urinary Tract Infections | 1983 |
The pharmacokinetics and efficacy of an aminoglycoside administered into the cerebral ventricles in neonates: implications for further evaluation of this route of therapy in meningitis.
Topics: Amikacin; Citrobacter; Escherichia coli Infections; Female; Follow-Up Studies; Humans; Infant; Infant, Newborn; Infant, Newborn, Diseases; Injections, Intraventricular; Kanamycin; Kinetics; Male; Meningitis; Meningomyelocele; Retrospective Studies | 1981 |
Isepamicin versus amikacin in the treatment of urinary tract infection.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Escherichia coli Infections; Female; Follow-Up Studies; Gentamicins; Humans; Male; Middle Aged; Prospective Studies; Pseudomonas aeruginosa; Pseudomonas Infections; Urinary Tract Infections | 1995 |
The efficacy and safety of isepamicin compared with amikacin in the treatment of intra-abdominal infections.
Topics: Adult; Amikacin; Anti-Bacterial Agents; Cholecystitis; Drug Administration Schedule; Escherichia coli; Escherichia coli Infections; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Metronidazole; Peritonitis; Pseudomonas aeruginosa; Pseudomonas Infections | 1995 |
Comparison of the efficacy and safety of isepamicin and amikacin in the treatment of skin and skin structure infections.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Drug Administration Schedule; Escherichia coli Infections; Female; Gentamicins; Gram-Negative Bacterial Infections; Humans; Male; Middle Aged; Proteus Infections; Proteus mirabilis; Pseudomonas aeruginosa; Pseudomonas Infections; Skin Diseases, Bacterial; Staphylococcal Skin Infections; Staphylococcus aureus | 1995 |
A randomised comparison of isepamicin and amikacin in the treatment of bacterial infections in paediatric patients.
Topics: Adolescent; Amikacin; Anti-Bacterial Agents; Bacterial Infections; Child; Child, Preschool; Drug Administration Schedule; Enterococcus faecalis; Escherichia coli Infections; Female; Gentamicins; Humans; Infant; Infant, Newborn; Klebsiella Infections; Klebsiella pneumoniae; Male; Staphylococcal Infections; Staphylococcus epidermidis; Streptococcal Infections | 1995 |
Isepamicin versus amikacin for the treatment of acute pyelonephritis in children.
Topics: Amikacin; Anti-Bacterial Agents; Child; Child, Preschool; Escherichia coli; Escherichia coli Infections; Female; Gentamicins; Humans; Infant; Infant, Newborn; Male; Pyelonephritis; Treatment Outcome; Urine | 2000 |
Comparison of amikacin and tobramycin in the treatment of infection in patients with cancer.
Topics: Adolescent; Adult; Aged; Amikacin; Anti-Bacterial Agents; Escherichia coli; Escherichia coli Infections; Female; Humans; Kanamycin; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Neoplasms; Pneumonia; Pseudomonas aeruginosa; Pseudomonas Infections; Sepsis; Tobramycin; Urinary Tract Infections | 1977 |
[Amikacin in urinary tract infections with so-called problem pathogens].
Topics: Amikacin; Clinical Trials as Topic; Drug Evaluation; Escherichia coli Infections; Humans; Kanamycin; Proteus Infections; Pseudomonas Infections; Urinary Tract Infections | 1976 |
102 other study(ies) available for amikacin and Escherichia coli Infections
Article | Year |
---|---|
First report of plasmid-mediated qnrA1 in a ciprofloxacin-resistant Escherichia coli strain in Latin America.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Conjugation, Genetic; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Integrons; Latin America; Molecular Sequence Data; Plasmids | 2007 |
Spread of extended-spectrum beta-lactamase CTX-M-producing escherichia coli clinical isolates in community and nosocomial environments in Portugal.
Topics: Aged; Anti-Bacterial Agents; beta-Lactamases; Community-Acquired Infections; Cross Infection; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Humans; Microbial Sensitivity Tests; Middle Aged; Portugal | 2007 |
First occurrence of an Escherichia coli clinical isolate producing the VIM-1/VIM-2 hybrid metallo-beta-lactamase VIM-12.
Topics: Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamases; Conjugation, Genetic; Escherichia coli; Escherichia coli Infections; Humans; Male; Microbial Sensitivity Tests; Plasmids; Recombination, Genetic | 2007 |
Escherichia coli isolate coproducing 16S rRNA Methylase and CTX-M-type extended-spectrum beta-lactamase isolated from an outpatient in the United States.
Topics: Ambulatory Care; Aminoglycosides; Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Female; Humans; Methyltransferases; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; RNA, Ribosomal, 16S; Sequence Analysis, DNA; United States | 2008 |
Plasmid-mediated qepA gene among Escherichia coli clinical isolates from Japan.
Topics: Anti-Bacterial Agents; Conjugation, Genetic; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Fluoroquinolones; Hospitals; Humans; Japan; Microbial Sensitivity Tests; Plasmids; Prevalence | 2008 |
Molecular characterization and epidemiology of extended-spectrum-beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates causing health care-associated infection in Thailand, where the CTX-M family is endemic.
Topics: Adult; Bacterial Proteins; beta-Lactamases; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Endemic Diseases; Escherichia coli; Escherichia coli Infections; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Polymerase Chain Reaction; Sequence Analysis, DNA; Thailand | 2008 |
Bloodstream infections caused by extended-spectrum-beta-lactamase- producing Escherichia coli: risk factors for inadequate initial antimicrobial therapy.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Multivariate Analysis; Risk Factors; Treatment Failure | 2008 |
Plasmid-mediated quinolone resistance pump QepA2 in an Escherichia coli isolate from France.
Topics: Aged; Base Sequence; DNA Primers; DNA, Bacterial; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Female; Fluoroquinolones; France; Genes, Bacterial; Humans; Models, Genetic; Molecular Sequence Data; Plasmids | 2008 |
High prevalence of ST131 isolates producing CTX-M-15 and CTX-M-14 among extended-spectrum-beta-lactamase-producing Escherichia coli isolates from Canada.
Topics: Bacterial Typing Techniques; beta-Lactamases; Canada; Community-Acquired Infections; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Humans; Microbial Sensitivity Tests; Prevalence; Urinary Tract Infections | 2010 |
Persistence of uropathogenic Escherichia coli in the face of multiple antibiotics.
Topics: Animals; Anti-Bacterial Agents; Biofilms; Cell Membrane Permeability; Cells, Cultured; Drug Resistance, Bacterial; Endosomes; Escherichia coli; Escherichia coli Infections; Female; Humans; Mice; Mice, Inbred CBA; Microbial Sensitivity Tests; Recurrence; Urinary Bladder; Urinary Tract Infections; Urothelium | 2010 |
Carbapenem-resistant KPC-2-producing Escherichia coli in a Tel Aviv Medical Center, 2005 to 2008.
Topics: Academic Medical Centers; Bacterial Proteins; Base Sequence; beta-Lactamases; Carbapenems; DNA Primers; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Escherichia coli; Escherichia coli Infections; Humans; In Vitro Techniques; Israel; Microbial Sensitivity Tests; Molecular Epidemiology; Plasmids; Time Factors | 2010 |
Incidence and antimicrobial susceptibility of Escherichia coli and Klebsiella pneumoniae with extended-spectrum beta-lactamases in community- and hospital-associated intra-abdominal infections in Europe: results of the 2008 Study for Monitoring Antimicrob
Topics: Abdomen; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cross Infection; Escherichia coli; Escherichia coli Infections; Humans; Klebsiella Infections; Klebsiella pneumoniae | 2010 |
Antibiogram and molecular characterization of multi-drug resistant microorganisms isolated from urinary tract infections.
Topics: Amikacin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Gentamicins; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Nitrofurantoin; Oxacillin; Pakistan; Pipemidic Acid; Piperacillin, Tazobactam Drug Combination; Polymyxin B; Pseudomonas aeruginosa; Pseudomonas Infections; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 2021 |
Analysis of drug resistance genes of integrons in clinical isolates of Escherichia coli from elderly bloodstream infections.
Topics: Aged; Amikacin; Anti-Bacterial Agents; beta-Lactamases; Cefepime; Cefoxitin; Clavulanic Acid; Drug Resistance; Escherichia coli; Escherichia coli Infections; Gentamicins; Humans; Integrons; Levofloxacin; Meropenem; Microbial Sensitivity Tests; Minocycline; Sepsis; Ticarcillin; Trimethoprim, Sulfamethoxazole Drug Combination | 2022 |
Genotypic resistance determined by whole genome sequencing versus phenotypic resistance in 234 Escherichia coli isolates.
Topics: Amikacin; Amoxicillin; Anti-Bacterial Agents; Cefepime; Cefotaxime; Ceftazidime; Ciprofloxacin; Clavulanic Acid; Escherichia coli; Escherichia coli Infections; Genotype; Gentamicins; Humans; Meropenem; Microbial Sensitivity Tests; Phenotype; Piperacillin; Retrospective Studies; Tazobactam; Tobramycin; Whole Genome Sequencing | 2023 |
Bacterial profile, antimicrobial resistance, and molecular detection of ESBL and quinolone resistance gene of uropathogens causing urinary tract infection in the southeastern part of Bangladesh.
Topics: Amikacin; Ampicillin; Anti-Bacterial Agents; Bangladesh; beta-Lactamases; Cefazolin; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Quinolones; RNA, Ribosomal, 16S; Urinary Tract Infections | 2023 |
In-Vitro Biofilm Formation and Antimicrobial Resistance of
Topics: Adolescent; Adult; Aged; Amikacin; Amoxicillin; Anti-Bacterial Agents; Biofilms; Cross-Sectional Studies; Diabetes Complications; Diabetes Mellitus; Disk Diffusion Antimicrobial Tests; Drug Resistance, Multiple, Bacterial; Escherichia coli Infections; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections; Uropathogenic Escherichia coli; Young Adult | 2019 |
Cefaclor as a first-line treatment for acute uncomplicated cystitis: a retrospective single-center study.
Topics: Adult; Aged; Aged, 80 and over; Amikacin; Ampicillin; Anti-Bacterial Agents; beta-Lactam Resistance; Cefaclor; Cefazolin; Cystitis; Drug Resistance, Multiple, Bacterial; Escherichia coli Infections; Female; Fosfomycin; Humans; Klebsiella Infections; Levofloxacin; Microbial Sensitivity Tests; Middle Aged; Proteus Infections; Retrospective Studies; Staphylococcal Infections; Treatment Failure; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections; Young Adult | 2020 |
Prevalence of O25b-ST131 clone and fosfomycin resistance in urinary Escherichia coli isolates and their relation to CTX-M determinant.
Topics: Amikacin; Anti-Bacterial Agents; beta-Lactamases; Ceftriaxone; Cefuroxime; Ciprofloxacin; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Fosfomycin; Humans; Meropenem; Microbial Sensitivity Tests; Polymerase Chain Reaction; Prevalence; Urinary Tract Infections; Virulence Factors | 2020 |
Nitrofurantoin Combined With Amikacin: A Promising Alternative Strategy for Combating MDR Uropathogenic
Topics: Amikacin; Anti-Bacterial Agents; Escherichia coli Infections; Humans; Nitrofurantoin; Urinary Tract Infections; Uropathogenic Escherichia coli | 2020 |
Single-dose amikacin plus 7 days of amoxicillin/clavulanate to treat acute cystitis caused by extended-spectrum beta-lactamase-producing
Topics: Acute Disease; Aged; Amikacin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Cystitis; Drug Administration Schedule; Escherichia coli; Escherichia coli Infections; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Retrospective Studies | 2021 |
Increased activity of colistin in combination with amikacin against Escherichia coli co-producing NDM-5 and MCR-1.
Topics: Amikacin; Animals; Anti-Bacterial Agents; beta-Lactamases; Colistin; Drug Resistance, Multiple, Bacterial; Drug Synergism; Drug Therapy, Combination; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Mice; Microbial Sensitivity Tests | 2017 |
Aminoglycosides Monotherapy as First-Line Treatment for Febrile Urinary Tract Infection in Children.
Topics: Adolescent; Amikacin; Anti-Bacterial Agents; Child; Child, Preschool; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Fever; Humans; Infant; Infant, Newborn; Male; Microbial Sensitivity Tests; Retrospective Studies; Urinary Tract Infections | 2017 |
Plasmid-Mediated Colistin Resistance Gene mcr-1 in an Escherichia coli ST10 Bloodstream Isolate in the Sultanate of Oman.
Topics: Amikacin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacteremia; Ciprofloxacin; Colistin; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Gene Expression; Humans; Membrane Proteins; Microbial Sensitivity Tests; Oman; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Plasmids; Protein Isoforms; Tetracycline; Trimethoprim, Sulfamethoxazole Drug Combination | 2018 |
Antibiotics susceptibility patterns of uropathogenic E. coli with special reference to fluoroquinolones in different age and gender groups.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Cefoperazone; Child; Child, Preschool; Cross-Sectional Studies; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Fluoroquinolones; Humans; Imipenem; Infant; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Sulbactam; Tazobactam; Urinary Tract Infections; Young Adult | 2017 |
Trend of Antibiotic Sensitivity of Escherichia Coli in Patients with Urinary Tract Infection.
Topics: Adolescent; Adult; Amikacin; Anti-Bacterial Agents; Drug Resistance, Microbial; Escherichia coli; Escherichia coli Infections; Female; Humans; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Nitrofurantoin; Urinary Tract Infections; Young Adult | 2017 |
Pharmacodynamic interactions of amikacin with selected β-lactams and fluoroquinolones against canine Escherichia coli isolates.
Topics: Amikacin; Animals; Anti-Bacterial Agents; beta-Lactams; Dog Diseases; Dogs; Drug Therapy, Combination; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Microbial Sensitivity Tests | 2018 |
Multidrug resistance, prevalence and phylogenetic analysis of genes encoding class II and III integrons in clinically isolated Escherichia coli.
Topics: Amikacin; Ampicillin; Anti-Bacterial Agents; Base Sequence; Cefotaxime; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Gene Expression Regulation, Bacterial; Gentamicins; Hospitals; Humans; Imipenem; Integrons; Microbial Sensitivity Tests; Nalidixic Acid; Ofloxacin; Phylogeny; Polymerase Chain Reaction; Prevalence; Saudi Arabia; Sequence Alignment | 2018 |
Infections Caused by Extended-Spectrum
Topics: Amikacin; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Case-Control Studies; Escherichia coli; Escherichia coli Infections; Female; Humans; Lupus Erythematosus, Systemic; Male; Microbial Sensitivity Tests; Middle Aged; Prevalence; Retrospective Studies; Risk Factors | 2018 |
Complete recovery in Wernicke's encephalopathy complicating hyperemesis gravidarum.
Topics: Amikacin; Anti-Bacterial Agents; Escherichia coli Infections; Female; Fluid Therapy; Humans; Hyperemesis Gravidarum; Infant, Extremely Premature; Infant, Premature, Diseases; Pregnancy; Pregnancy, Triplet; Thiamine; Thiamine Deficiency; Treatment Outcome; Wernicke Encephalopathy; Young Adult | 2019 |
Endometritis and Bacteremia With a New Delhi Metallo-Beta-Lactamase 1 (NDM-1)-containing Organism in a Remote Traveler.
Topics: Adult; Amikacin; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Ceftriaxone; Cesarean Section; Drug Resistance, Bacterial; Endometritis; Escherichia coli; Escherichia coli Infections; Female; Fetal Membranes, Premature Rupture; Humans; India; Nucleic Acid Amplification Techniques; Ontario; Pregnancy; Pregnancy, Twin; Puerperal Infection; Travel | 2019 |
Pharmacodynamics of plazomicin and a comparator aminoglycoside, amikacin, studied in an in vitro pharmacokinetic model of infection.
Topics: Amikacin; Anti-Bacterial Agents; Bacterial Load; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Sisomicin | 2019 |
Molecular and Phenotypic Characteristics of
Topics: Agriculture; Amikacin; Ampicillin; Animals; Cefoxitin; China; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Humans; Microbial Sensitivity Tests; Mink; Tetracycline | 2019 |
Positive culture for extended-spectrum β-lactamase during acute prostatitis after prostate biopsy is a risk factor for progression to chronic prostatitis.
Topics: Aged; Amikacin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; beta-Lactamases; Blood; Cefoxitin; Disease Progression; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; Image-Guided Biopsy; Imipenem; Male; Microbial Sensitivity Tests; Middle Aged; Prostate; Prostatitis; Quinolones; Urine | 2013 |
Emergency hospital admissions attributable to infective complications of prostate biopsy despite appropriate prophylaxis: need for additional infection prevention strategies?
Topics: Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacteremia; Ciprofloxacin; Cross-Sectional Studies; Drug Resistance, Bacterial; Emergencies; Endoscopic Ultrasound-Guided Fine Needle Aspiration; Escherichia coli; Escherichia coli Infections; Humans; Incidence; Length of Stay; London; Male; Middle Aged; Patient Admission; Prostate; Rectum; Retrospective Studies; Systemic Inflammatory Response Syndrome; Urinary Retention | 2014 |
Risk factors associated with preoperative fecal carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae in liver transplant recipients.
Topics: Adult; Amikacin; beta-Lactamases; beta-Lactams; Cefoxitin; Ciprofloxacin; Drug Resistance, Bacterial; End Stage Liver Disease; Enterobacter cloacae; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Escherichia coli Infections; Feces; Female; Humans; Imipenem; Klebsiella; Klebsiella Infections; Klebsiella pneumoniae; Liver Transplantation; Logistic Models; Male; Microbial Sensitivity Tests; Middle Aged; Multivariate Analysis; Penicillanic Acid; Peritonitis; Piperacillin; Piperacillin, Tazobactam Drug Combination; Preoperative Period; Risk Factors; Severity of Illness Index | 2014 |
Frequency distribution of genes encoding aminoglycoside modifying enzymes in uropathogenic E. coli isolated from Iranian hospital.
Topics: Amikacin; Anti-Bacterial Agents; Disk Diffusion Antimicrobial Tests; Drug Resistance, Bacterial; Escherichia coli Infections; Gene Expression Regulation, Bacterial; Gene Frequency; Genes, Bacterial; Gentamicins; Hospitals, Teaching; Humans; Iran; Kanamycin; Netilmicin; Tobramycin; Urinary Tract Infections; Uropathogenic Escherichia coli | 2014 |
Treatment of recurrent complicated urinary tract infections in children with vesicoureteral reflux.
Topics: Adolescent; Amikacin; Anti-Bacterial Agents; Ceftazidime; Child; Child, Preschool; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Escherichia coli; Escherichia coli Infections; Female; Fosfomycin; Humans; Infant; Male; Pilot Projects; Recurrence; Retrospective Studies; Taiwan; Urinary Tract Infections; Vesico-Ureteral Reflux | 2016 |
Hepatic abscess originating from renal suppurative collection.
Topics: Abdominal Pain; Abscess; Adult; Amikacin; Anti-Bacterial Agents; Ciprofloxacin; Escherichia coli; Escherichia coli Infections; Humans; Kidney Diseases; Liver Abscess; Male; Multidetector Computed Tomography; Treatment Outcome | 2015 |
Molecular characterization of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella spp. isolates in Mongolia.
Topics: Amikacin; Anti-Bacterial Agents; Bacterial Typing Techniques; beta-Lactamases; Carbapenems; Electrophoresis, Gel, Pulsed-Field; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Fluoroquinolones; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Mongolia; Plasmids; Polymerase Chain Reaction | 2016 |
First Report of the IncI1/ST898 Conjugative Plasmid Carrying rmtE2 16S rRNA Methyltransferase Gene in Escherichia coli.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Base Sequence; Conjugation, Genetic; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Gene Expression Regulation, Bacterial; Gentamicins; Methyltransferases; Microbial Sensitivity Tests; Molecular Sequence Data; Phylogeny; Plasmids; Point Mutation; Swine; Swine Diseases | 2015 |
Characteristics of Plasmids Coharboring 16S rRNA Methylases, CTX-M, and Virulence Factors in Escherichia coli and Klebsiella pneumoniae Isolates from Chickens in China.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Bacterial Proteins; Bacteriocin Plasmids; beta-Lactamases; Cefotaxime; Chickens; China; Conjugation, Genetic; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Klebsiella Infections; Klebsiella pneumoniae; Methyltransferases; Microbial Sensitivity Tests; Polymerase Chain Reaction; RNA, Ribosomal, 16S; tRNA Methyltransferases; Virulence Factors | 2015 |
Pharmacodynamics of nine generic products of amikacin compared with the innovator in the neutropenic mouse thigh infection model.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Disease Models, Animal; Escherichia coli Infections; Mice; Neutropenia | 2015 |
[The comparison of antibiotic susceptibilities of uropathogenic Escherichia coli isolates in transition from CLSI to EUCAST].
Topics: Amikacin; Ampicillin; Anti-Bacterial Agents; Bacteriuria; Cefuroxime; Ciprofloxacin; Disk Diffusion Antimicrobial Tests; Drug Resistance, Bacterial; Escherichia coli Infections; European Union; Gentamicins; Humans; Imipenem; Levofloxacin; Microbial Sensitivity Tests; Reference Standards; Sulbactam; Trimethoprim, Sulfamethoxazole Drug Combination; Turkey; Urinary Tract Infections; Uropathogenic Escherichia coli | 2015 |
Antimicrobial susceptibility of clinical Enterobacteriaceae isolates at the emergency department in a regional hospital: A threat of extended spectrum beta-lactamase-producers among nursing home residents.
Topics: Amikacin; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Blood; Drug Resistance, Multiple, Bacterial; Emergency Service, Hospital; Ertapenem; Escherichia coli; Escherichia coli Infections; Female; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Male; Meropenem; Microbial Sensitivity Tests; Nursing Homes; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Proteus Infections; Proteus mirabilis; Retrospective Studies; Sputum; Taiwan; Thienamycins; Urine | 2016 |
Amikacin therapy for urinary tract infections caused by extended-spectrum β-lactamase-producing Escherichia coli.
Topics: Adult; Aged; Aged, 80 and over; Ambulatory Care; Amikacin; beta-Lactamase Inhibitors; beta-Lactamases; Drug Administration Schedule; Escherichia coli; Escherichia coli Infections; Humans; Microbial Sensitivity Tests; Middle Aged; Recurrence; Remission Induction; Retrospective Studies; Time Factors; Treatment Outcome; Urinalysis; Urinary Tract Infections; Urine | 2016 |
Neonatal Conjunctivitis Leading to Neonatal Sepsis--A Case Report.
Topics: Amikacin; Anti-Bacterial Agents; Conjunctivitis; Escherichia coli; Escherichia coli Infections; Humans; Infant, Newborn; Male; Meropenem; Sepsis; Thienamycins; Treatment Outcome | 2016 |
[Characterization of class 1 and class 2 integron gene cassettes in Escherichia coli strains isolated from urine cultures: a multicenter study].
Topics: Amikacin; Ampicillin; Anti-Bacterial Agents; Bacteriuria; Escherichia coli Infections; Humans; Imipenem; Integrons; Microbial Sensitivity Tests; Polymerase Chain Reaction; Sequence Analysis, DNA; Streptomycin; Trimethoprim, Sulfamethoxazole Drug Combination; Turkey; Urinary Tract Infections; Uropathogenic Escherichia coli | 2016 |
In vitro potency of amikacin and comparators against E. coli, K. pneumoniae and P. aeruginosa respiratory and blood isolates.
Topics: Administration, Inhalation; Adolescent; Adult; Aged; Amikacin; Anti-Bacterial Agents; beta-Lactams; Cross Infection; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Humans; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Middle Aged; Models, Statistical; Pseudomonas aeruginosa; Pseudomonas Infections; United States | 2016 |
Prospective study analyzing risk factors and characteristics of healthcare-associated infections in a Urology ward.
Topics: Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Catheters, Indwelling; Cross Infection; Cystectomy; Drug Resistance, Microbial; Enterococcus; Escherichia coli; Escherichia coli Infections; Female; Fluoroquinolones; Hospital Units; Humans; Immunosuppression Therapy; Incidence; Klebsiella; Klebsiella Infections; Male; Middle Aged; Prospective Studies; Pseudomonas aeruginosa; Pseudomonas Infections; Risk Factors; Surgical Wound Infection; Urinary Catheters; Urinary Tract Infections; Urology; Vancomycin | 2017 |
Inadequate timing between corticosteroid and antibiotics applications increases mortality due to sepsis.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Drug Administration Schedule; Escherichia coli Infections; Glucocorticoids; Klebsiella Infections; Male; Methylprednisolone; Mice; Sepsis; Staphylococcal Infections; Teicoplanin | 2008 |
Composition of the outer membrane proteins of Escherichia coli strains in relation to serum susceptibility after exposure to subinhibitory concentrations of amikacin and ciprofloxacin.
Topics: Amikacin; Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Child; Ciprofloxacin; Cystitis; Escherichia coli; Escherichia coli Infections; Humans; Serum; Serum Bactericidal Test | 2009 |
Effect of aminglycoside administration on the occurrence and multiplication of resistant bacteria.
Topics: Amikacin; Aminoglycosides; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Escherichia coli; Escherichia coli Infections; Genotype; Gentamicins; Humans; Netilmicin; Pseudomonas aeruginosa; Pseudomonas Infections | 2009 |
KPC-2 producing Klebsiella pneumoniae and Escherichia coli co-infection in a catheter-related infection.
Topics: Aged, 80 and over; Amikacin; Anti-Bacterial Agents; beta-Lactamases; Catheter-Related Infections; Community-Acquired Infections; Drug Resistance, Multiple, Bacterial; Escherichia coli Infections; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Pneumonia, Bacterial; Thienamycins | 2011 |
Antimicrobial resistance in more than 100,000 Escherichia coli isolates according to culture site and patient age, gender, and location.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Ampicillin; Anti-Bacterial Agents; Cefotaxime; Child; Child, Preschool; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Fosfomycin; Humans; Imipenem; Infant; Male; Middle Aged; Nitrofurantoin; Retrospective Studies; Tobramycin; Young Adult | 2011 |
[Investigation of the susceptibilities of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp. strains to ertapenem and other carbapenems].
Topics: Amikacin; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carbapenems; Ertapenem; Escherichia coli; Escherichia coli Infections; Humans; Imipenem; Klebsiella Infections; Klebsiella oxytoca; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Thienamycins | 2011 |
Susceptibility of European Escherichia coli clinical isolates from intra-abdominal infections, extended-spectrum β-lactamase occurrence, resistance distribution, and molecular characterization of ertapenem-resistant isolates (SMART 2008-2009).
Topics: Amikacin; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Drug Resistance, Bacterial; Ertapenem; Escherichia coli; Escherichia coli Infections; Europe; Female; Humans; Imipenem; Intraabdominal Infections; Male; Microbial Sensitivity Tests | 2012 |
The major aminoglycoside-modifying enzyme AAC(3)-II found in Escherichia coli determines a significant disparity in its resistance to gentamicin and amikacin in China.
Topics: Acetyltransferases; Amikacin; Anti-Bacterial Agents; China; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Gentamicins; Humans; Isoenzymes; Microbial Sensitivity Tests; Prevalence; Sequence Analysis, DNA | 2012 |
Activity of plazomicin (ACHN-490) against MDR clinical isolates of Klebsiella pneumoniae, Escherichia coli, and Enterobacter spp. from Athens, Greece.
Topics: Amikacin; Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Enterobacter; Enterobacteriaceae Infections; Escherichia coli; Escherichia coli Infections; Gentamicins; Greece; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Sisomicin; Tertiary Care Centers; Tobramycin | 2012 |
[Dermohypodermitis and gut translocation Escherichia coli septicemia in a newborn infant].
Topics: Abdomen; Amikacin; Amoxicillin; Anti-Bacterial Agents; Bacteremia; Bacterial Translocation; Cefotaxime; Escherichia coli; Escherichia coli Infections; Feces; Female; Fever; Humans; Infant, Newborn; Infant, Newborn, Diseases; Skin Diseases; Thorax; Treatment Outcome | 2013 |
Lung deposition and efficiency of nebulized amikacin during Escherichia coli pneumonia in ventilated piglets.
Topics: Administration, Inhalation; Amikacin; Animals; Anti-Bacterial Agents; Bronchopneumonia; Disease Models, Animal; Dose-Response Relationship, Drug; Escherichia coli Infections; Injections, Intravenous; Lung; Nebulizers and Vaporizers; Pneumonia, Bacterial; Respiration, Artificial; Severity of Illness Index; Swine; Treatment Outcome | 2002 |
[Examination of urogenital tract microorganism infection and antibiotic susceptibility test].
Topics: Adult; Amikacin; Cefazolin; Chlamydia; Corynebacterium; Escherichia coli; Escherichia coli Infections; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Prostatitis; Rifampin; Staphylococcal Infections; Staphylococcus epidermidis; Urethritis; Uterine Cervicitis | 2003 |
Fournier's gangrene associated with sparganosis in the scrotum.
Topics: Alcoholism; Amikacin; Animals; Cefazolin; Debridement; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Escherichia coli Infections; Food Parasitology; Fournier Gangrene; Humans; Male; Meat; Middle Aged; Ranidae; Scrotum; Snakes; Sparganosis; Streptococcal Infections | 2004 |
[Complicating neonatal Escherichia coli meningitis].
Topics: Amikacin; Brain; Drug Therapy, Combination; Echoencephalography; Empyema, Subdural; Escherichia coli Infections; Female; Fosfomycin; Humans; Infant, Newborn; Intensive Care, Neonatal; Magnetic Resonance Imaging; Meningitis, Escherichia coli; Meropenem; Microbial Sensitivity Tests; Patient Care Team; Thienamycins; Treatment Outcome | 2004 |
Isolation of an amikacin-resistant Escherichia coli strain after tobramycin treatment of previous recurrent episodes of respiratory tract infections caused by Pseudomonas aeruginosa.
Topics: Amikacin; Anti-Bacterial Agents; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Humans; Integrons; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Recurrence; Respiratory Tract Infections; Tobramycin | 2005 |
Clarithromycin co-administered with amikacin attenuates systemic inflammation in experimental sepsis with Escherichia coli.
Topics: Acute Disease; Amikacin; Animals; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Escherichia coli; Escherichia coli Infections; Female; Humans; Inflammation; Lipopolysaccharides; Malondialdehyde; Pyelonephritis; Rabbits; Sepsis; Treatment Outcome; Tumor Necrosis Factor-alpha | 2005 |
Clarithromycin: immunomodulatory therapy of experimental sepsis and acute pyelonephritis by Escherichia coli.
Topics: Acute Disease; Amikacin; Animals; Anti-Bacterial Agents; Caspase 3; Caspases; Clarithromycin; Colony Count, Microbial; Escherichia coli; Escherichia coli Infections; Immunologic Factors; Male; Malondialdehyde; Pulmonary Edema; Pyelonephritis; Rabbits; Sepsis; Tumor Necrosis Factor-alpha | 2005 |
A high prevalence of antimicrobial resistant Escherichia coli isolated from pigs and a low prevalence of antimicrobial resistant E. coli from cattle and sheep in Great Britain at slaughter.
Topics: Amikacin; Amoxicillin-Potassium Clavulanate Combination; Animals; Anti-Infective Agents; Cattle; Cattle Diseases; Ceftazidime; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Gene Expression Regulation, Bacterial; Microbial Sensitivity Tests; Polymerase Chain Reaction; Prevalence; Reverse Transcriptase Polymerase Chain Reaction; Sheep, Domestic; Streptomycin; Swine; Swine Diseases; Tetracycline; United Kingdom | 2008 |
Uropathogens and empiric antibiotics for the treatment of urinary tract infections in spinal cord injured patients at rehabilitation center, Thai Red Cross Society during 2001 to 2005.
Topics: Adult; Amikacin; Anti-Bacterial Agents; Cephalosporins; Escherichia coli Infections; Female; Health Status Indicators; Humans; Length of Stay; Male; Prevalence; Red Cross; Rehabilitation Centers; Retrospective Studies; Sickness Impact Profile; Societies, Medical; Spinal Cord Injuries; Thailand; Urinary Tract Infections | 2007 |
Antimicrobial resistance of Esherichia coli urinary isolates from primary care patients in Greece.
Topics: Adolescent; Adult; Amikacin; Ampicillin Resistance; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Greece; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Primary Health Care; Retrospective Studies; Urinary Tract Infections | 2008 |
Infected chylothorax caused by Escherichia coli in a non- immunocompromised child.
Topics: Amikacin; Anti-Bacterial Agents; Child, Preschool; Chylothorax; Escherichia coli Infections; Humans; Immunocompetence; Male; Treatment Outcome | 2008 |
[Our experience with sodium cefoperazone].
Topics: Amikacin; Cefoperazone; Drug Synergism; Escherichia coli Infections; Humans; Meningitis; Pseudomonas Infections; Urinary Tract Infections | 1984 |
Escherichia coli infections in knee joints. The pharmacological and antibacterial effects of intramuscular antibiotics.
Topics: Amikacin; Animals; Arthritis, Infectious; Carbenicillin; Drug Synergism; Drug Therapy, Combination; Escherichia coli; Escherichia coli Infections; Injections, Intramuscular; Kanamycin; Knee Joint; Microbial Sensitivity Tests; Rabbits; Synovial Fluid | 1980 |
Experimental infection in rabbits evoked by Pseudomonas aeruginosa, Proteus mirabilis, Escherichia coli and Klebsiella pneumoniae treated with gentamicin, amikacin and sisomicin.
Topics: Amikacin; Animals; Enterobacteriaceae Infections; Escherichia coli Infections; Gentamicins; Kanamycin; Klebsiella Infections; Klebsiella pneumoniae; Proteus Infections; Proteus mirabilis; Pseudomonas Infections; Rabbits; Sisomicin | 1980 |
The use of biodegradable amikacin microspheres to prevent vascular graft infection.
Topics: Amikacin; Animals; Aorta; Biodegradation, Environmental; Dogs; Dose-Response Relationship, Drug; Escherichia coli; Escherichia coli Infections; Microspheres; Prosthesis-Related Infections; Staphylococcal Infections; Staphylococcus aureus | 1994 |
[Septicemia in early stage of severe burns].
Topics: Adult; Aged; Amikacin; Bacteremia; Burns; Escherichia coli Infections; Female; Humans; Male; Middle Aged; Penicillins; Shock; Staphylococcal Infections; Time Factors | 1993 |
Absorbable, delayed-release antibiotic beads reduce surgical wound infection.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Antibiotic Prophylaxis; Drug Implants; Escherichia coli Infections; Guinea Pigs; Male; Minocycline; Polyglycolic Acid; Staphylococcal Infections; Surgical Wound Infection | 1997 |
Comparison of amikacin dosing regimens in neutropenic guinea pigs with Escherichia coli infection.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Escherichia coli Infections; Female; Guinea Pigs; Half-Life; Leukocyte Count; Male; Metabolic Clearance Rate; Neutropenia; Neutrophils; Reference Values | 1998 |
Efficacy of cefepime and amikacin in the empiric treatment of febrile neutropenic children with cancer.
Topics: Adolescent; Amikacin; Anti-Bacterial Agents; Bacteremia; Cefepime; Cephalosporins; Child; Child, Preschool; Drug Therapy, Combination; Escherichia coli Infections; Female; Fever; Fever of Unknown Origin; Humans; Infant; Male; Neoplasms; Neutropenia; Staphylococcal Infections; Streptococcal Infections; Treatment Outcome | 2000 |
Nonenteric Escherichia coli isolates from dogs: 674 cases (1990-1998).
Topics: Amikacin; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Dog Diseases; Dogs; Drug Resistance, Microbial; Enrofloxacin; Escherichia coli; Escherichia coli Infections; Female; Fluoroquinolones; Gentamicins; Infections; Male; Microbial Sensitivity Tests; Norfloxacin; Quinolones; Respiratory System; Retrospective Studies; Skin; Urine | 2001 |
Comparison of four aminoglycoside antibiotics in the therapy of experimental E. coli meningitis.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Escherichia coli; Escherichia coli Infections; Gentamicins; Kanamycin; Meningitis; Rabbits; Sisomicin; Tobramycin | 1977 |
Amikacin and cephalothin: empiric regimen for granulocytopenic cancer patients.
Topics: Adult; Agranulocytosis; Amikacin; Cephalothin; Drug Therapy, Combination; Escherichia coli Infections; Female; Humans; Kanamycin; Male; Neoplasms; Pseudomonas Infections | 1977 |
Amikacin therapy of gram-negative bacteremia and meningitis. Treatment in diseases due to multiple resistant bacilli.
Topics: Adolescent; Adult; Aged; Amikacin; Cross Infection; Drug Resistance, Microbial; Enterobacteriaceae Infections; Escherichia coli Infections; Humans; Kanamycin; Klebsiella Infections; Meningitis; Proteus Infections; Sepsis; Serratia marcescens | 1978 |
Rapid development of resistance of gentamicin, tobramycin and amikacin by E. coli 07..
Topics: Adult; Amikacin; Anti-Bacterial Agents; Drug Resistance, Microbial; Escherichia coli; Escherichia coli Infections; Gentamicins; Humans; Kanamycin; Male; Tobramycin | 1978 |
Amikacin in gram-negative paediatric infections.
Topics: Adolescent; Amikacin; Bacterial Infections; Child; Child, Preschool; Escherichia coli Infections; Female; Gastrointestinal Diseases; Humans; Infant; Infant, Newborn; Kanamycin; Klebsiella Infections; Male; Respiratory Tract Infections; Skin Diseases; Urinary Tract Infections | 1978 |
Amikacin in the treatment of genito-urinary tract infections in cancer patients.
Topics: Adult; Aged; Amikacin; Cystitis; Escherichia coli Infections; Female; Humans; Kanamycin; Male; Middle Aged; Pseudomonas Infections; Pyelonephritis; Urinary Bladder Neoplasms | 1978 |
Intraventricular administration of amikacin for complicated Gram-negative meningitis and ventriculitis.
Topics: Acinetobacter Infections; Amikacin; Child, Preschool; Encephalitis; Enterobacteriaceae Infections; Escherichia coli Infections; Female; Humans; Infant; Infant, Newborn; Injections, Intraventricular; Kanamycin; Klebsiella Infections; Klebsiella pneumoniae; Male; Meningitis; Serratia marcescens | 1979 |
Antibiotic penetration of synovial fluid in infected and normal knee joints.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Bacterial Infections; Carbenicillin; Cefazolin; Cefoxitin; Cephalothin; Escherichia coli Infections; Gentamicins; Humans; Joint Diseases; Knee Joint; Rabbits; Synovial Fluid | 1978 |
Efficacy of amikacin in septic abortion: serum and urine antibiotic concentrations.
Topics: Abortion, Septic; Adolescent; Adult; Amikacin; Curettage; Escherichia coli Infections; Female; Humans; Kanamycin; Pregnancy | 1976 |
[A case of E. coli septicemia successfully treated with amikacin (author's transl)].
Topics: Amikacin; Carbenicillin; Cefazolin; Drug Therapy, Combination; Escherichia coli Infections; Gentamicins; Humans; Kanamycin; Male; Middle Aged; Sepsis | 1975 |
[Effect of TFX (Polfa) on the course of experimental bacterial infections in mice treated with ciprofloxacin, amikacin and cefoperazone].
Topics: Amikacin; Animals; Cefoperazone; Ciprofloxacin; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drug Interactions; Drug Therapy, Combination; Escherichia coli Infections; Female; Male; Mice; Mice, Inbred BALB C; Staphylococcal Infections; Staphylococcus aureus; Thymus Extracts | 1992 |
[Diffusion of amikacin into the sinuses in patients with nosocomial sinusitis. Administration of a single dose per day].
Topics: Adult; Aged; Amikacin; Bacteroides Infections; Cross Infection; Diffusion; Dose-Response Relationship, Drug; Drug Therapy, Combination; Escherichia coli Infections; Female; Humans; Injections, Intravenous; Male; Middle Aged; Paranasal Sinuses; Sinusitis; Streptococcal Infections | 1992 |
[Bacteriology of neonatal septicemia in Dakar].
Topics: Amikacin; Anti-Bacterial Agents; Bacteremia; Bacterial Infections; Enterobacteriaceae Infections; Escherichia coli Infections; Female; Humans; Incidence; Infant, Newborn; Klebsiella Infections; Male; Senegal; Staphylococcal Infections; Streptococcal Infections | 1992 |
Experimental bacterial prostatitis in rats.
Topics: Amikacin; Animals; Enterococcus faecalis; Escherichia coli Infections; Male; Prostatitis; Pyelonephritis; Rats; Rats, Inbred Strains; Streptococcal Infections; Urethra | 1991 |
Biochemical and pharmacodynamic studies of simple renal cyst fluids in relation to infection.
Topics: Adult; Aged; Amikacin; Bacterial Infections; Body Fluids; Drainage; Escherichia coli Infections; Female; Humans; Inhalation; Kidney Diseases, Cystic; Male; Middle Aged | 1991 |
Escherichia coli sepsis and prolonged hypophosphatemia following exertional heat stroke.
Topics: Adolescent; Amikacin; Escherichia coli Infections; Fluid Therapy; Heat Exhaustion; Humans; Male; Phosphates | 1990 |
[An epidemiologic study of the antibiotic susceptibility of bacteria isolated from patients with urinary tract infections].
Topics: Adolescent; Adult; Amikacin; Anti-Bacterial Agents; Bacteria; Cefotaxime; Escherichia coli; Escherichia coli Infections; Female; Humans; Male; Middle Aged; Ofloxacin; Prevalence; Turkey; Urinary Tract Infections | 1989 |
[Combined chemotherapy of experimental infection in neutropenia].
Topics: Agranulocytosis; Amikacin; Animals; Azlocillin; Cefotaxime; Drug Synergism; Drug Therapy, Combination; Escherichia coli Infections; Immune Tolerance; Klebsiella Infections; Mice; Neutropenia; Opportunistic Infections; Pseudomonas Infections | 1989 |
Combination therapy: a way to limit emergence of resistance?
Topics: Amikacin; Animals; Anti-Bacterial Agents; Ceftriaxone; Drug Resistance, Microbial; Drug Therapy, Combination; Enterobacter; Enterobacteriaceae Infections; Escherichia coli; Escherichia coli Infections; Female; Klebsiella Infections; Klebsiella pneumoniae; Mice; Mice, Inbred ICR; Norfloxacin; Pefloxacin; Pseudomonas aeruginosa; Pseudomonas Infections; Serratia marcescens; Staphylococcal Infections; Staphylococcus aureus; Time Factors | 1986 |
Ceftazidime and amikacin alone and in combination against Pseudomonas aeruginosa and Enterobacteriaceae.
Topics: Amikacin; Animals; Ceftazidime; Drug Synergism; Drug Therapy, Combination; Enterobacteriaceae Infections; Escherichia coli; Escherichia coli Infections; Klebsiella Infections; Klebsiella pneumoniae; Neutropenia; Pseudomonas aeruginosa; Pseudomonas Infections; Rabbits; Serratia marcescens | 1987 |
Effects of single-dose and three-day trimethoprim-sulfadiazine and amikacin treatment of induced Escherichia coli urinary tract infections in dogs.
Topics: Amikacin; Animals; Anti-Infective Agents, Urinary; Bacteriuria; Dog Diseases; Dogs; Drug Administration Schedule; Drug Combinations; Escherichia coli Infections; Female; Male; Random Allocation; Sulfadiazine; Trimethoprim; Urinary Tract Infections | 1988 |
Treatment of chronic prostatitis: intraprostatic antibiotic injections under echography control.
Topics: Amikacin; Chronic Disease; Escherichia coli Infections; Humans; Injections; Male; Prostate; Prostatitis; Time Factors; Tobramycin; Ultrasonography | 1988 |